Updated on 2023/12/25

写真a

 
SUZUKI Shuhei
 
Title
Assistant Professor

Research Areas

  • Oncology

 

Research Career

  • Oncology, 2012.04 -

Papers

  • Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson's disease, as an anti-cancer stem cell drug, ONCOTARGET, 8(55) 94872-94882, 2017.11

    Okada Masashi, Takeda Hiroyuki, Sakaki Hirotsugu, Kuramoto Kenta, Suzuki Shuhei, Sanomachi Tomomi, Togashi Keita, Seino Shizuka, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents, ANTICANCER RESEARCH, 37(11) 6177-6188, 2017.11

    Sanomachi Tomomi, Suzuki Shuhei(*co-first), Kuramoto Kenta, Takeda Hiroyuki, Sakaki Hirotsugu, Togashi Keita, Seino Shizuka, Yoshioka Takashi, Okada Masashi, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo, ONCOTARGET, 8(53) 90979-90991, 2017.10

    Takeda Hiroyuki, Okada Masashi, Kuramoto Kenta, Suzuki Shuhei, Sakaki Hirotsugu, Sanomachi Tomomi, Seino Shizuka, Yoshioka Takashi, Hirano Hirofumi, Arita Kazunori, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • Licochalcone A specifically induces cell death in glioma stem cells via mitochondrial dysfunction, FEBS OPEN BIO, 7(6) 835-844, 2017.06

    Kuramoto Kenta, Suzuki Shuhei, Sakaki Hirotsugu, Takeda Hiroyuki, Sanomachi Tomomi, Seino Shizuka, Narita Yoshitaka, Kayama Takamasa, Kitanaka Chifumi, Okada Masashi

    Multiple Authorship (Only Japanese)

  • Long-term survival after a favorable response to anti-EGFR antibody plus chemotherapy to treat bone marrow metastasis: a case report of KRAS-wildtype rectal cancer, ONCOTARGETS AND THERAPY, 10 1143-1147, 2017

    Nakamura Sho, Fukui Tadahisa, Suzuki Shuhei, Takeda Hiroyuki, Watanabe Kaname, Yoshioka Takashi

    Multiple Authorship (Only Japanese)

  • Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine, ANTICANCER RESEARCH, 36(12) 6311-6318, 2016.12

    Takeda Hiroyuki, Okada Masashi, Suzuki Shuhei, Kuramoto Kenta, Sakaki Hirotsugu, Watarai Hikaru, Sanomachi Tomomi, Seino Shizuka, Yoshioka Takashi, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin, ANTICANCER RESEARCH, 36(11) 6083-6092, 2016.11

    Watarai Hikaru, Okada Masashi, Kuramoto Kenta, Takeda Hiroyuki, Sakaki Hirotsugu, Suzuki Shuhei, Seino Shizuka, Oizumi Hiroyuki, Sadahiro Mitsuaki, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance, ANTICANCER RESEARCH, 36(10) 5153-5161, 2016.10

    Suzuki Shuhei, Okada Masashi, Kuramoto Kenta, Takeda Hiroyuki, Sakaki Hirotsugu, Watarai Hikaru, Sanomachi Tomomi, Seino Shizuka, Yoshioka Takashi, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo, ONCOTARGET, 7(19) 27021-27032, 2016.05

    Okada Masashi, Kuramoto Kenta, Takeda Hiroyuki, Watarai Hikaru, Sakaki Hirotsugu, Seino Shizuka, Seino Manabu, Suzuki Shuhei, Kitanaka Chifumi

    Multiple Authorship (Including Foreigners)

  • Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel, ONCOLOGY REPORTS, 35(1) 593-601, 2016.01

    Seino Manabu, Okada Masashi, Sakaki Hirotsugu, Takeda Hiroyuki, Watarai Hikaru, Suzuki Shuhei, Seino Shizuka, Kuramoto Kenta, Ohta Tsuyoshi, Nagase Satoru, Kurachi Hirohisa, Kitanaka Chifumi

    Multiple Authorship (Including Foreigners)

  • The Role of Cancer Boards in the Treatment Decisions Regarding Chemotherapy, INTERNAL MEDICINE, 55(21) 3119-3123, 2016

    Nakamura Sho, Fukui Tadahisa, Sasahara Yuriko (Ito), Suzuki Shuhei, Takeda Hiroyuki, Miwa Misako, Ichikawa Mayumi, Nemoto Kenji, Yamakawa Mayumi, Yoshioka Takashi

    Multiple Authorship (Including Foreigners)

  • GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells, ANTICANCER RESEARCH, 35(12) 6607-6614, 2015.12

    Sakaki Hirotsugu, Okada Masashi, Kuramoto Kenta, Takeda Hiroyuki, Watarai Hikaru, Suzuki Shuhei, Seino Shizuka, Seino Manabu, Ohta Tsuyoshi, Nagase Satoru, Kurachi Hirohisa, Kitanaka Chifumi

    Multiple Authorship (Including Foreigners)

  • Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells, CANCER RESEARCH, 75 , 2015.08

    Seino Manabu, Okada Masashi, Shibuya Keita, Seino Shizuka, Suzuki Shuhei, Takeda Hiroyuki, Ohta Tsuyoshi, Kurachi Hirohisa, Ito Kiyoshi, Nagase Satoru, Kitanaka Chifumi

    Multiple Authorship (Including Foreigners)

  • Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells, ONCOTARGET, 6(2) 651-661, 2015.01

    Shibuya Keita, Okada Masashi, Suzuki Shuhei, Seino Manabu, Seino Shizuka, Takeda Hiroyuki, Kitanaka Chifumi

    Multiple Authorship (Including Foreigners)

  • JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells, ONCOTARGET, 6(1) 458-470, 2015.01

    Suzuki Shuhei, Okada Masashi, Shibuya Keita, Seino Manabu, Sato Atsushi, Takeda Hiroyuki, Seino Shizuka, Yoshioka Takashi, Kitanaka Chifumi

    Multiple Authorship (Including Foreigners)

  • Differential Contribution of ROS to Resveratrol-induced Cell Death and Loss of Self-renewal Capacity of Ovarian Cancer Stem Cells, ANTICANCER RESEARCH, 35(1) 85-96, 2015.01

    Seino Manabu, Okada Masashi, Shibuya Keita, Seino Shizuka, Suzuki Shuhei, Takeda Hiroyuki, Ohta Tsuyoshi, Kurachi Hirohisa, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • Requirement of JNK Signaling for Self-renewal and Tumor-initiating Capacity of Ovarian Cancer Stem Cells, ANTICANCER RESEARCH, 34(9) 4723-4731, 2014.09

    Seino Manabu, Okada Masashi, Shibuya Keita, Seino Shizuka, Suzuki Shuhei, Ohta Tsuyoshi, Kurachi Hirohisa, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • Targeting the K-Ras - JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation, ONCOTARGET, 5(13) 5100-5112, 2014.07

    Okada Masashi, Shibuya Keita, Sato Atsushi, Seino Shizuka, Suzuki Shuhei, Seino Manabu, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression, INTERNATIONAL JOURNAL OF ONCOLOGY, 44(2) 591-599, 2014.02

    Okada Masashi, Sato Atsushi, Shibuya Keita, Watanabe Eriko, Seino Shizuka, Suzuki Shuhei, Seino Manabu, Narita Yoshitaka, Shibui Soichiro, Kayama Takamasa, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells, ONCOLOGY REPORTS, 30(4) 1957-1964, 2013.10

    Okada Masashi, Shibuya Keita, Sato Atsushi, Seino Shizuka, Watanabe Eriko, Suzuki Shuhei, Seino Manabu, Kitanaka Chifumi

    Multiple Authorship (Only Japanese)

  • Two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin,leading to clinical complete response., International Cancer Conference Journal, 2013.02

    Shuhei Suzuki,Yuriko Ito,Tadahisa Fukui,Mika Orihara,Sho Nakamura,Masahiro Takahashi,Hiroto Fujimoto,Wataru Kimura,Takashi Yoshioka

    Multiple Authorship (Including Foreigners)

  • Two cases of gastric cancer with peritoneal carcinomatosis successfully responding to combination chemotherapy of S-1 and cisplatin,leading to clinical complete response., International Cancer Conference Journal, 2(4) 201-205, 2013

    Suzuki Shuhei, Ito Yuriko, Fukui Tadahisa, Orihara Mika, Nakamura Sho, Takahashi Masahiro, Fujimoto Hroto, Kimura Wataru, Yoshioka Takashi.

    Multiple Authorship (Only Japanese)

display all >>

Review Papers

  • がん幹細胞におけるJNK経路の機能解析, 生命科学系学会合同年次大会運営事務局, 生命科学系学会合同年次大会, 2017年度 [1P-0950], 2017.12

    岡田 雅司, 鈴木 修平, 倉元 謙太, 武田 弘幸, 北中 千史

Academic Awards Received

  • Yamagata University Medical Society Academic Award, second-place prize, 2018.02, Others, Shuhei Suzuki

  • Inoue Research Award for Young Scientists, 2017.12, Others, Shuhei Suzuki

  • Yamagata University Medical Society Academic Award , 2016.02, Others, Shuhei Suzuki

  • Yamagata University Alumni Association Award , 2016.02, Others, Shuhei Suzuki

Grant-in-Aid for Scientific Research

  • Grant-in-Aid for Scientific Research(C)，2022.04 - 2025.03

  • Grant-in-Aid for Scientific Research(C)，2022.04 - 2023.03

  • Grant-in-Aid for Scientific Research(C)，2019.04 - 2022.03

  • Grant-in-Aid for Young Scientists(B)，2017.04 - 2019.03

Other external funds procured

  • Grant-in-Aid for Scientific Research, Grant-in-Aid for Young Scientists (B)，2017.04 - 2019.03，Development of safe and effective cancer stem cell treatments by new anti-psychotics

    Ministry of Education, Culture, Sports, Science and Technology

  • Grant-in-Aid for Scientific Research, Grant-in-Aid for Young Scientists (B)，2015.04 - 2017.03，Overcome of Cancer Stem Cell Chemoresistance via JNK signaling

    Ministry of Education, Culture, Sports, Science and Technology